Cargando…
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells
Attempts to develop a therapeutic vaccine against human papillomavirus (HPV)-induced malignancies have mostly not been clinically successful to date. One reason may be the hypoxic microenvironment present in most tumors, including cervical cancer. Hypoxia dysregulates the levels of human leukocyte a...
Autores principales: | Mohan, Nitya, Wellach, Kathrin, Özerdem, Ceren, Veits, Nisha, Förster, Jonas D., Foehr, Sophia, Bonsack, Maria, Riemer, Angelika B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634485/ https://www.ncbi.nlm.nih.gov/pubmed/36341354 http://dx.doi.org/10.3389/fimmu.2022.918528 |
Ejemplares similares
-
Characterization of DoTc2 4510—Identifying HPV16 Presence in a Cervical Carcinoma Cell Line Previously Considered to Be HPV-Negative
por: Vučković, Nika, et al.
Publicado: (2023) -
Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice
por: Schifflers, Christoph, et al.
Publicado: (2023) -
A Targeted LC‐MS Strategy for Low‐Abundant HLA Class‐I‐Presented Peptide Detection Identifies Novel Human Papillomavirus T‐Cell Epitopes
por: Blatnik, Renata, et al.
Publicado: (2018) -
Generation of affibody molecules specific for HPV16 E7 recognition
por: Xue, Xiangyang, et al.
Publicado: (2016) -
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein
por: Rodolico, Vito, et al.
Publicado: (2011)